Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE reverses decision on medication for relapsing multiple sclerosis

March 16, 2017
Sales and Marketing Biogen, zinbryta

The current topic of discussion regarding NICE is how its recent changes will impact patient access to medicine but, away …

News
7808465302_a335c6dd4f_o

The rising threat of antibiotic resistance

March 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …

Feature
nice_reception_small_size

NICE drug expense limit of £20 million could cause treatment delays

March 16, 2017
Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease

NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …

News
china-pharmaceutical-industry

FDA warns China’s Lumis over misbranded APIs

March 16, 2017
Manufacturing and Production FDA, Lumis

Chinese firm Lumis Global Pharmaceuticals became the latest to face the FDA’s ire as it was hit by a warning …

News
pills-384846_960_720

US city takes drug company to court over opioid crisis

March 16, 2017
Medical Communications OxyContin, opioid, opioid crisis

The opioid crisis in North America continues to rumble on, ruining lives and causing untold damage to communities. One city, …

News
fdaoutsideweb

Trump’s proposed budget doubles FDA regulatory fees

March 16, 2017
Sales and Marketing FDA, Trump

Trump’s presidency could cost the industry more than twice as much in regulatory review fees next year, as his administration …

News
tablets

Ibuprofen linked to 31% increase in risk of cardiac arrest

March 16, 2017
Medical Communications cardiac arrest, ibuprofen

A study emerging from Denmark has found that the use of over-the-counter pain killer, Ibuprofen, is associated with an increased …

News

SHL to Present at Pharmapack Symposium Taiwan 2017

March 16, 2017
Manufacturing and Production auto injectors, extractables and leachables, prefilled syringe

Olle Ljungquist, Senior Scientist at SHL Group, will give a talk on the “Requirements and Test Methods for Finished Prefilled …

News
Press release
heartbeat

Decade lifespan difference in Americans and Canadians with cystic fibrosis

March 15, 2017
Research and Development Canada, United States, cystic fibrosis

A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …

News
opdivo_1_1

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017
Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …

News
shutterstock_156022646

FDA-approved preterm birth drug has no benefit and may cause harm, study suggests

March 15, 2017
Research and Development FDA, Makena

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …

News
merck_and_co

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017
Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …

News
sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017
Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …

News

Novartis secures first-line FDA approval in breast cancer indication

March 14, 2017
Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer

The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …

News
cancer_cells

Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer

March 14, 2017
Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR

New research emerging from the Institute for Cancer Research (ICR) has found that those previously treated for Hodgkin lymphoma are …

News
sun_pharma

FDA lifts block on Sun Pharma facility

March 14, 2017
Manufacturing and Production FDA, Sun Pharma

Sun Pharma has announced that the FDA informed it that the Import Alert in place upon its Mohali manufacturing facility …

News
breast_cancer

One in five women with breast cancer could benefit from existing therapy

March 14, 2017
Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors

A new study emerging from the Wellcome Trust Sanger Institute has discovered that there are more cases of breast cancer …

News
deborah

XTuit Pharmaceuticals move to appoint biotech veteran as CEO

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals

XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …

Appointment
mylan

Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche

March 13, 2017
Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar

Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …

News
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …

Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026